Authorized generics are identical to brand-name drugs in every way except the label. Learn why they're therapeutically equivalent, how they differ from regular generics, and when to choose them for better adherence and peace of mind.
Continue Reading...
Tentative approval lets generic drug makers get ahead in line for FDA approval, but they can't sell until patents expire. Patent litigation, strict deadlines, and regulatory moves determine who gets to market first-and who loses millions.
Continue Reading...
The Orange Book is the FDA's official list of approved drugs with therapeutic equivalence ratings. It enables generic drug competition, saves billions annually, and helps patients access affordable medications.
Continue Reading...
The Hatch-Waxman Act of 1984 revolutionized U.S. drug policy by creating the modern generic drug approval system. It cut costs, boosted access, and balanced innovation with affordability-changing healthcare for millions.
Continue Reading...
Combo pills may seem convenient, but when made from generic ingredients, they often cost 10x more than buying the same drugs separately. Here's how to spot the overcharges and save hundreds a month.
Continue Reading...
Pharmacists regularly substitute brand-name drugs with generics to cut costs, but patient skepticism, lack of doctor communication, and risks with certain medications make this practice far more complex than it seems.
Continue Reading...
Serious adverse events from generic drugs are underreported due to unclear manufacturer identification. Learn how to report reactions correctly, why the system fails, and what’s being done to fix it.
Continue Reading...
Generic medications are just as safe and effective as brand-name drugs, but many patients still have questions. Learn the facts about bioequivalence, cost savings, side effects, and when generics might need extra monitoring.
Continue Reading...
